Kura Oncology Shares Early Commercial Results for Leukemia Treatment

San Diego, Sunday, 11 January 2026.
Kura Oncology generated $2.1 million in initial sales for its newly approved leukemia drug, supporting a robust $667 million cash position as the company targets 2026 expansion.